MPX International Corporation (MPXOF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: Jan 7, 2026
MPX International Market Cap
MPX International has a market cap or net worth of $14.43 thousand as of January 21, 2026. Its market cap has decreased by -96.77% in one year.
Market Cap
14.43K
Enterprise Value
n/a
Revenue
5.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 6, 2019, MPX International's market cap has decreased from 27.37M to 14.43K, a decrease of -99.95%. That is a compound annual growth rate of -66.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 14.43K | 9,922.22% |
| Dec 31, 2025 | 144.00 | -99.91% |
| Dec 31, 2024 | 158.76K | 110,146.53% |
| Dec 27, 2023 | 144.00 | -99.98% |
| Dec 30, 2022 | 584.51K | -84.31% |
| Dec 31, 2021 | 3.73M | -53.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 6, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |